Facile conversion of Biginelli 3,4-dihydropyrimidin-2(1H)-thiones to 2-(2-hydroxy-2-arylvinyl) dihydropyrimidines via Eschenmoser coupling

Tetrahedron Letters

Volumn 50, Issue 16, 2009, Pages 1838-1843

  Singh, Sukhdeep ^a   Schober, Andreas ^a   Gebinoga, Michael ^a   Alexander Gross G ^a  

^a ILMENAU UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Biginelli; DHPM; Drug research; Eschenmoser; Eschenmoser coupling; Polymer supported; Privileged structure; Sulfide contraction; Triphenylphosphine

Indexed keywords

2 (2 HYDROXY 2 ARYLVINYL) DIHYDROPYRIMIDINE; 3,4 DIHYDROPYRIMIDIN 2(1H) THIONE; PYRIMIDINE DERIVATIVE; SULFIDE; SULFUR; THIOKETONE; TRIPHENYLPHOSPHINE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; BIGINELLI REACTION; CHEMICAL REACTION; ELIMINATION REACTION; ESCHENMOSER COUPLING; ONE POT SYNTHESIS;

EID: 61349100776     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2009.02.027     Document Type: Article

References (24)

1. Kappe C.O. Eur. J. Med. Chem. 35 (2000) 1043-1052
2. Singh, K.; Arora, D.; Singh. K.; Singh, S. Mini Rev. Med. Chem. 2009, 9, 95-106.
3. Biginelli P. Gazz. Chim. Ital. 23 (1893) 360-416
4. Kappe C.O. Tetrahedron 49 (1993) 6937-6963
5. Dallinger D., and Kappe C.O. Pure Appl. Chem. 77 (2005) 155-161
6. Singh K., Singh S., and Mahajan A. J. Org. Chem. 70 (2005) 6114-6117
7. Gross A.G., Wurziger H., and Schober A. J. Comb. Chem. 8 (2006) 153-155
8. Singh K., Arora D., and Singh S. Tetrahedron. Lett. 48 (2007) 1349-1352
9. Singh K., and Singh S. Tetrahedron 64 (2008) 11718-11723
10. Deres K., Schroeder C.H., Paessens A., Goldmann S., Hacker H.J., Weber O., Kramer T., Niewoehner U., Pleiss U., Stoltefuss J., Graef E., Koletzki D., Masantschek R.N.A., Reimann A., Jaeger R., Grob R., Beckermann B., Schlemmer K.-H., Haebich D., and Ruebsamen-Waigmann H. Science 299 (2003) 893-896
11. Mayer T.U., Kapoor T.M., Haggarty S.J., King R.W., Schreiber S.L., and Mitchison T.J. Science 286 (1999) 971-974
12. Barrow J.C., Nantermet P.G., Selnick H.G., Glass K.L., Rittle K.E., Gilbert K.F., Steele T.G., Homnick C.F., Freidinger R.M., Ransom R.W., Kling P., Reiss D., Broten T.P., Schorn T.W., Chang R.S.L., O'Malley S.S., Olah T.V., Ellis J.D., Barrish A., Kassahun K., Leppert P., Nagarathnam D., and Forray C. J. Med. Chem. 43 (2000) 2703-2718
13. Franklin A.S., Ly S.K., Mackin G.H., Overman L.E., and Shaka A.J. J. Org. Chem. 64 (1999) 1512-1519
14. The Merck Index, An Encyclopedia of Chemicals, Drugs and Biologicals, 13th ed., Merck Whitehouse Station, 2001.
15. Atwal K.S., Rovnyak G.C., O'Reilly B.C., and Schwartz J. J. Org. Chem. 54 (1989) 5898-5907
16. O'Reilly B.C., and Atwal K.S. Heterocycles 26 (1987) 1185-1188
17. Atwal K.S., O'Reilly B.C., Gougoutas J.Z., and Malley M.F. Heterocycles 26 (1987) 1189-1192
18. Lengar A., and Kappe C.O. Org. Lett. 6 (2004) 771-774
19. Gholap A.R., Toti K.S., Shirazi F., Deshpande M.V., and Srinivasan K.V. Tetrahedron 64 (2008) 10214-10223
20. Kang F.A., Kodah J., Guan Q.Y., Li X.B., and Murray W.V. J. Org. Chem. 70 (2005) 1957-1960
21. Matloobi M., and Kappe C.O. J. Comb. Chem. 9 (2007) 275-284
22. Roth M., Dubs P., Gotschi E., and Eschenmoser A. Helv. Chim. Acta 54 (1971) 710-734
23. Balkan A., Uma S., Ertan M., and Wiegrebe W. Pharmazie 47 (1992) 687-688
24. 1H NMR spectra of all products 11 show two sets of signals with approximate 3:1 intensity. This is due to different conformations of the C2-C bond as well as the possible tautomerism of the dihydropyrimidin core 11.